Chronic News and Research

RSS

Medivir AB announces license agreement with Daewoong Pharmaceutical for MIV-210 drug

Medivir AB (Sweden) today announced a license agreement with Daewoong Pharmaceutical Co. Ltd., (South Korea) for its hepatitis B virus (HBV) polymerase inhibitor drug, lagociclovir valactate (MIV-210).

12 Mar 2010

Children with chronic illness more likely to develop H1N1 influenza: Study

As critical care professionals develop a better understanding of the progression of H1N1, they are becoming better prepared to treat children with severe cases, according to a new study that will be published in the March issue of Pediatric Critical Care Medicine (PCCM).

12 Mar 2010

PolyMedix presents data from PMX-30063 defensin-mimetic antibiotic compound Phase 1B study at 8th TSIS

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has presented for the first time to the medical community data from its Phase 1B clinical study with its defensin-mimetic antibiotic compound, PMX-30063.

12 Mar 2010

Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment

Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.

12 Mar 2010

Azur Pharma to acquire PRIALT analgesic therapy from Elan Pharmaceuticals

Azur Pharma Limited today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).

12 Mar 2010

Intel, Mayo Clinic and GE launch new initiative to study care and benefits of home-based telemedicine

Emerging Healthcare Solutions, Inc. was pleased on learning the news that Intel, The Mayo Clinic and GE Healthcare have launched a new initiative to study the care and cost benefits of home-based telemedicine for elderly patients with chronic illnesses.

11 Mar 2010

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City's African-American and Latino communities.

11 Mar 2010

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).

11 Mar 2010

DaVita recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), has been recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010 for the fifth consecutive year.

11 Mar 2010

WHO FCTC celebrates fifth anniversary

A ceremony marking the fifth anniversary of the entry into force of the WHO Framework Convention on Tobacco Control (FCTC) was held today in the Geneva headquarters of the World Health Organization.

11 Mar 2010

National Public Health Agenda for Osteoarthritis launched with assistance from UNC

Betty Isaacs of Boone, N.C., knows all about the chronic pain of osteoarthritis and the impact it has on her life. "The pain in my knee was so bad, I would just sit around," Isaacs said.

11 Mar 2010

Save Flexible Spending Plans, WageWorks issue statement on FSA restrictions

President Obama and Democratic leaders in Congress are currently planning to require restrictions on the use of flexible spending accounts (FSAs) – most significantly in the form of a $2,500 cap on FSA contributions and new limits on the use of the benefit to cover the cost of over-the-counter medications – to take effect next year.

11 Mar 2010

New changes made to the Dose Conversion Guidelines on Fentanyl Transdermal Systems

The manufacturers of Fentanyl Transdermal Systems, in collaboration with Health Canada, would like to inform Canadians of important new changes made to the Dose Conversion Guidelines in the Product Monograph. These guidelines are used to help determine what dosage of Fentanyl Transdermal Systems is appropriate for each individual patient.

11 Mar 2010

Key stakeholder groups convene to address noncommunicable diseases at Global Forum

The first Global Forum of the Noncommunicable Disease Network (NCDnet) marks the first time WHO has convened key stakeholder groups to address the large-scale and increasing global health and development burden posed by noncommunicable diseases (NCDs).

11 Mar 2010

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net). Poor, minority adults with moderate to severe CKD are also two to four times more likely to progress to kidney failure than non-Hispanic whites.

11 Mar 2010

XenaCare Holdings' Cobroxin to be available for purchase in Walgreens

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation’s largest pharmacy chains with 7,162 drugstores located throughout the United States.

11 Mar 2010

AAOS 2010 meeting highlights emerging incidence of pediatric sports injuries

At today's 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), two separate studies focus on the dramatic rise of pediatric sports injuries in recent years. However, despite this alarming trend, awareness, education, warning signs and early treatment can make a significant difference and help keep these athletes in the game, according to the study experts.

11 Mar 2010

Sleep disorders may increase risk of cardiovascular and metabolic diseases

Many Americans will lose an hour of sleep on March 14, the first day of daylight-saving time, when clocks are set ahead one hour at 2 a.m. local standard time—making it harder to wake up, causing difficulty in staying alert and increasing the chance of sleepy-driving car crashes.

11 Mar 2010

6 Day Dental and Orthodontics improves access to oral health care

6 Day Dental and Orthodontics now accepts Medicaid and CHIP at all five 6 Day locations – in Allen, Coppell, Frisco/Plano, Flower Mound and Roanoke/Keller.

11 Mar 2010

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Legislators need pork to make things happen, especially in an age when chronic obstruction has so weakened the legislative process that policy breakthroughs are almost impossible. This does not excuse all kinds of deal making, nor should we ignore that deals sometimes go too far (Julian E. Zelizer, 3/10).

10 Mar 2010

Chronic News and Research

Medivir AB announces license agreement with Daewoong Pharmaceutical for MIV-210 drug

Children with chronic illness more likely to develop H1N1 influenza: Study

PolyMedix presents data from PMX-30063 defensin-mimetic antibiotic compound Phase 1B study at 8th TSIS

Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment

Azur Pharma to acquire PRIALT analgesic therapy from Elan Pharmaceuticals

Intel, Mayo Clinic and GE launch new initiative to study care and benefits of home-based telemedicine

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

DaVita recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010

WHO FCTC celebrates fifth anniversary

National Public Health Agenda for Osteoarthritis launched with assistance from UNC

Save Flexible Spending Plans, WageWorks issue statement on FSA restrictions

New changes made to the Dose Conversion Guidelines on Fentanyl Transdermal Systems

Key stakeholder groups convene to address noncommunicable diseases at Global Forum

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

XenaCare Holdings' Cobroxin to be available for purchase in Walgreens

AAOS 2010 meeting highlights emerging incidence of pediatric sports injuries

Sleep disorders may increase risk of cardiovascular and metabolic diseases

6 Day Dental and Orthodontics improves access to oral health care

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News